Wang et al. demonstrated that miR-29 is downregulated in RMS, particularly in aRMS, and acts as a tumor suppressor by targeting genes involved in extracellular matrix remodeling and cell adhesion, such as COL1A1, COL1A2, and MMP2 [14]. The gene discussed is MMP2; the disease is neoplasm.